has Walmart shared where (now former) primary care patients are being referred?

how are they mitigating patient abandonment concerns?

for researchers and tinkerers interested in contributing to AI benchmark development (esp in healthcare and bio) check out this opportunity at MLCommons 👇🏽

as the discourse shifts from models to compound AI systems / agents, we need better AI benchmarks to evaluate multi-modal and multi-step task performance, especially in healthcare and life sciences.

when we wrote the first paper demonstrating ChatGPT's performance on the USMLE,

For medicine, how do good, mid-sized, general LLMs (which may be partially trained on medical text) compare in performance to models built on medical resources like PubMed? We find that the general-purpose models now do better (Bolton, Xiong, et al. 2024)

arxiv.org/abs/2404.15894

new medicines rooted in genetics have a 3x greater likelihood of success compared to those that lack genetic support #SDDS2024

heading to the Stanford Medicine Drug Discovery Symposium this week. DM me if you're in town and want to link up!

.NEJM AI Volume 1, No. 5 is now live!

this issue covers a number of urgent concerns for AI x biomedicine, including:
• LLM underperformance on automated medical coding tasks
• Challenges of integrating AI into traditional healthcare reimbursement models
• The effectiveness

this week in bio:
• why Mars is tough for life
• an autoantibody signature for MS
• selective compartmentalization for proteins
• AI-designed CRISPR
• RNAi-based drug design

decodingbio.com/p/biobyte-074-…

open-source models can be a strong lever for increasing gross margins at AI companies, especially those that have hefty cost structures (e.g., enterprise sales orgs that require significant customer success or implementation resources, as well forward-deployed AI services models

bio/health/ai friends - going to be in LA next week, drop me a line if you're around and want to meet up!

ICYMI, this week NEJM AI welcomed several new Associate Editors to help ensure that high quality, leading-edge biomedical AI research is carefully reviewed and widely disseminated. congrats!

follow their work: Enrico Coiera Roxana Daneshjou MD/PhD Sam Finlayson Venk Murthy MD PhD Roy Perlis

In the latest episode of the AI Grand Rounds podcast, Dr. Daphne Koller charts her professional trajectory, tracing her early fascination with computers to her influential role in AI and health care.

🎧 Listen to the full episode: nejm.ai/ep17

as a self-loathing but new adoptee of business frameworks, i’m here to announce that the matrix is dead.

enter the 2D higher-order tensor McKinsey & Company

1/ From the moment we began working together, we knew MemorialCare would be a special partner—and it's been absolutely magical. ✨

Read more: abridge.com/press-release/…

Taking another big step forward today Recursion as we lead TechBio with the appointment of Najat Khan, PhD to our Board of Directors and as Chief R&D Officer and Chief Commercial Officer. Najat is one of the most progressive and pragmatic thinkers in the TechBio space, and